Comparative efficacy of everolimus plus exemestane versus fulvestrant for hormone-receptor-positive advanced breast cancer following progression/recurrence after endocrine therapy: a network meta-analysis

Postmenopausal women with advanced breast cancer recurring/progressing on or after initial (adjuvant or first-line) endocrine therapy may be treated multiple times with one of several endocrine or combinatorial targeted treatment options before initiating chemotherapy. In the absence of direct head-...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachelot, Thomas, McCool, Rachael, Duffy, Steven, Glanville, Julie, Varley, Danielle, Fleetwood, Kelly, Zhang, Jie, Jerusalem, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889833/
https://www.ncbi.nlm.nih.gov/pubmed/24272078
http://dx.doi.org/10.1007/s10549-013-2778-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889833/
https://www.ncbi.nlm.nih.gov/pubmed/24272078
http://dx.doi.org/10.1007/s10549-013-2778-5

Ejemplares similares